| |
|
|
|
Catabasis Pharma  
|
|
3.02 0.14 (0.05%) |
03-01 16:00 |
|
Open: |
2.93 |
Pre close: |
2.88 |
Target:
|
6.80
|
|
High: |
3.06 |
Low: |
2.91 |
Resistance:
|
5.82
7.97
|
|
Volume: |
661,047 |
Market Cap: |
71M |
Support:
|
2.35
1.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.94
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
3.31 |
Signal(12,26,9): |
0.13 |
|
MA(100): |
2.87 |
Stochastic Oscillator |
%K(14,3):
|
17.51  |
|
MA(250): |
4.73 |
%D(3): |
17.61 |
|
Average Volume(K) |
3-Month: |
1013904
|
52-Week |
High:
|
8.59 |
|
10-Days: |
179960 |
Low: |
1.25 |
|
RSI |
RSI(14):
|
48.65 |
Change(%): |
-40.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.141 |
Return on Equity (ttm) |
-79.8 |
Shares Out. (M) |
20.08 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-43.7 |
Shares Float (M) |
20.06 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.13 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
40.64 |
|
Forward EPS |
-2.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1240 |
|
Book Value (p.s.) |
2.460 |
EBITDA (p.s.) |
-1.752 |
P/E |
-1.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.23 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-32.19 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.49 |
P/CF |
-1.88 |
|
|
|
|
|
|
